Effect of Hyoscine and Promethazine on Labor Pain
Information source: Mashhad University of Medical Sciences
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Labor Pain
Intervention: Hyoscine (Drug); Promethazine (Drug)
Phase: Phase 2/Phase 3
Status: Completed
Sponsored by: Mashhad University of Medical Sciences
Summary
It is always considered to shorten the duration of delivery without compromising the mother
and fetus by obstetrics. Hyoscine and Promethazine are used widely in hospital and research
is very limited, with conflicting results regarding the efficacy of these two drugs. So the
investigators decided to compare of effect of hyoscine N-butyl bromide and Promethazine on
length of active phase of the first stage of labor.
Clinical Details
Official title: Principal Investigator
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
Primary outcome: Effect of Hyoscine and Promethazine on labor pain
Eligibility
Minimum age: 18 Years.
Maximum age: 35 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- 18-35 yrs,
- primiparous,
- having single fetus with cephalic presentation, gestational age 37-42 weeks,
- having no medical diseases,
- having no history of hospitalization due to psychological diseases,
- having no addiction to cigarette,
- having no complications during pregnancy such as hypertension,
- BMI< 26
Exclusion Criteria:
- bleeding
- CPD
- use of PG or Oxytocin
- fetus distress
Locations and Contacts
Additional Information
Starting date: August 2010
Last updated: July 19, 2012
|